These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. Di Sarno A; Landi ML; Cappabianca P; Di Salle F; Rossi FW; Pivonello R; Di Somma C; Faggiano A; Lombardi G; Colao A J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688 [TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital. Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404 [TBL] [Abstract][Full Text] [Related]
4. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine. Boulanger CM; Mashchak CA; Chang RJ Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327 [TBL] [Abstract][Full Text] [Related]
6. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830 [TBL] [Abstract][Full Text] [Related]
7. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy. Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260 [TBL] [Abstract][Full Text] [Related]
8. [A case of oligozoospermia with marginal hyperprolactinemia due to pituitary microadenoma]. Kawano M; Yasumoto R; Tsujino T; Masuda C; Sakakura T; Nishisaka N; Kishimoto T Hinyokika Kiyo; 1996 Apr; 42(4):319-21. PubMed ID: 8693969 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Sabuncu T; Arikan E; Tasan E; Hatemi H Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944 [TBL] [Abstract][Full Text] [Related]
10. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment. Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874 [TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up. Berinder K; Stackenäs I; Akre O; Hirschberg AL; Hulting AL Clin Endocrinol (Oxf); 2005 Oct; 63(4):450-5. PubMed ID: 16181238 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients. Ciccarelli E; Giusti M; Miola C; Potenzoni F; Sghedoni D; Camanni F; Giordano G J Clin Endocrinol Metab; 1989 Oct; 69(4):725-8. PubMed ID: 2570790 [TBL] [Abstract][Full Text] [Related]
13. Pregnancy in hyperprolactinemic infertile women treated with vaginal bromocriptine: report of two cases and review of the literature. Ricci G; Giolo E; Nucera G; Pozzobon C; De Seta F; Guaschino S Gynecol Obstet Invest; 2001; 51(4):266-70. PubMed ID: 11408739 [TBL] [Abstract][Full Text] [Related]
14. Bromocriptine for infertile males with mild hyperprolactinemia: hormonal and spermatogenic effects. Nishimura K; Matsumiya K; Tsuboniwa N; Yamanaka M; Koga M; Miura H; Tsujimura A; Uchida K; Kondoh N; Kitamura M; Okuyama A Arch Androl; 1999; 43(3):207-13. PubMed ID: 10624504 [TBL] [Abstract][Full Text] [Related]
15. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case]. Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885 [TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia. Long-term effects of bromocriptine. Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052 [TBL] [Abstract][Full Text] [Related]
18. Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment. Tørring O; Isberg B; Sjöberg HE; Bucht E; Hulting AL Acta Endocrinol (Copenh); 1993 May; 128(5):423-7. PubMed ID: 8317189 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine. Tartagni M; Nicastri PL; Diaferia A; Di Gesù I; Loizzi P Clin Exp Obstet Gynecol; 1995; 22(4):301-6. PubMed ID: 8777784 [TBL] [Abstract][Full Text] [Related]
20. Naval aviator with pituitary prolactin secreting microadenoma: case report and aeromedical concerns. Weiss DK Aviat Space Environ Med; 2000 Sep; 71(9):935-8. PubMed ID: 11001348 [No Abstract] [Full Text] [Related] [Next] [New Search]